Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors
Authors:
- 31 August 2016
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 161 (12) , 3331-3344
Abstract
Dengue is an arboviral disease with no effective therapy available. Therefore, there is an urgent need to find a potent antiviral agent against dengue virus (DENV). In the present study, salidroside, a main bioactive compound of Rhodiola rosea, was evaluated for its antiviral potential against DENV serotype-2 infection and its effect on host innate immune factors. Antiviral effects of salidroside were examined in DENV-infected cells by western blotting, flow cytometry and real-time PCR. Its underlying mechanism involved in antiviral action was determined by evaluating expression of host innate immune factors including RIG-I, IRF-3, IRF-7, PKR, P-eIF2α and NF-κB. Salidroside potently inhibited DENV infection by decreasing DENV envelope protein expression more than tenfold. Salidroside exerts its antiviral activity by increasing expression of RNA helicases such as RIG-I, thereby initiating a downstream signaling cascade that induces upregulation of IRF-3 and IRF-7. It prevents viral protein synthesis by increasing the expression of PKR and P-eIF2α while decreasing NF-κB expression. It was also found to induce the expression of IFN-α. In addition, the number of NK cells and CD8+ T cells were also found to be increased by salidroside treatment in human PBMCs, which are important in limiting DENV replication during early stages of infection. The findings presented here suggest that salidroside exhibits antiviral activity against DENV by inhibiting viral protein synthesis and boosting host immunity by increasing the expression of host innate immune factors and hence could be considered for the development of an effective therapeutic agent against DENV infection.Keywords
Funding Information
- Ministry of Defence (DIP-264)
This publication has 27 references indexed in Scilit:
- Mechanisms of RIG-I-Like Receptor Activation and Manipulation by Viral PathogensJournal of Virology, 2014
- NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cellsFrontiers in Immunology, 2014
- Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytesArchives of Virology, 2014
- Salidroside attenuates LPS-induced pro-inflammatory cytokine responses and improves survival in murine endotoxemiaInternational Immunopharmacology, 2011
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineVaccine, 2011
- The Complexity of Antibody-Dependent Enhancement of Dengue Virus InfectionViruses, 2010
- Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006PLOS Neglected Tropical Diseases, 2010
- Dengue Vaccines Approach the Finish LineClinical Infectious Diseases, 2007
- Selection for Virulent Dengue Viruses Occurs in Humans and MosquitoesJournal of Virology, 2005
- Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic CascadeClinical Infectious Diseases, 1989